Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Engelborghs

Showing results (141-150 of 359) with videos related to

Pageof 36
Sort By:
Acta Neuropathologica|August 15, 2012
The genetics and neuropathology of frontotemporal lobar degenerationAnne Sieben, Tim Van Langenhove, Sebastiaan Engelborghs, et al.
Journal of Alzheimer'S Disease : JAD|January 31, 2015
Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia DiagnosisHanne Struyfs, Bianca Van Broeck, Maarten Timmers, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2010
Comprehensive genetic and mutation analysis of familial dementia with Lewy bodies linked to 2q35-q36Bram Meeus, Karen Nuytemans, David Crosiers, et al.
Brain : a Journal of Neurology|June 26, 2007
No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's diseaseSebastiaan Engelborghs, Kristel Sleegers, Patrick Cras, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 16, 2023
Evaluation of Cognitive Functioning Before and After Cochlear Implantation in Adults Aged 55 Years and Older at Risk for Mild Cognitive ImpairmentEllen Andries, Joyce Bosmans, Sebastiaan Engelborghs, et al.
American Journal of Human Genetics|May 11, 2006
Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer diseaseJessie Theuns, Nathalie Brouwers, Sebastiaan Engelborghs, et al.
Alzheimer'S Research & Therapy|August 19, 2019
Souvenaid in the management of mild cognitive impairment: an expert consensus opinionJeffrey Cummings, Peter Passmore, Bernadette McGuinness, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 2, 2022
Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratiosFemke H Bouwman, Giovanni B Frisoni, Sterling C Johnson, et al.
BMC Neurology|September 1, 2017
Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic strokeAnn De Vos, Maria Bjerke, Raf Brouns, et al.
Journal of Alzheimer'S Disease : JAD|October 8, 2016
Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without DepressionDoortje W Dekens, Petrus J W Naudé, Sebastiaan Engelborghs, et al.
Pageof 36

Showing results (141-150 of 359) with videos related to

Sort By:
Pageof 36
Acta Neuropathologica|August 15, 2012
The genetics and neuropathology of frontotemporal lobar degenerationAnne Sieben, Tim Van Langenhove, Sebastiaan Engelborghs, et al.
Journal of Alzheimer'S Disease : JAD|January 31, 2015
Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia DiagnosisHanne Struyfs, Bianca Van Broeck, Maarten Timmers, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2010
Comprehensive genetic and mutation analysis of familial dementia with Lewy bodies linked to 2q35-q36Bram Meeus, Karen Nuytemans, David Crosiers, et al.
Brain : a Journal of Neurology|June 26, 2007
No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's diseaseSebastiaan Engelborghs, Kristel Sleegers, Patrick Cras, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 16, 2023
Evaluation of Cognitive Functioning Before and After Cochlear Implantation in Adults Aged 55 Years and Older at Risk for Mild Cognitive ImpairmentEllen Andries, Joyce Bosmans, Sebastiaan Engelborghs, et al.
American Journal of Human Genetics|May 11, 2006
Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer diseaseJessie Theuns, Nathalie Brouwers, Sebastiaan Engelborghs, et al.
Alzheimer'S Research & Therapy|August 19, 2019
Souvenaid in the management of mild cognitive impairment: an expert consensus opinionJeffrey Cummings, Peter Passmore, Bernadette McGuinness, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 2, 2022
Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratiosFemke H Bouwman, Giovanni B Frisoni, Sterling C Johnson, et al.
BMC Neurology|September 1, 2017
Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic strokeAnn De Vos, Maria Bjerke, Raf Brouns, et al.
Journal of Alzheimer'S Disease : JAD|October 8, 2016
Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without DepressionDoortje W Dekens, Petrus J W Naudé, Sebastiaan Engelborghs, et al.
Pageof 36